Treatment Response
8
4
5
1
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 8 trials
100.0%
+13.4% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 1 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 1 completed trials
Clinical Trials (8)
Multimodalomics-based Construction of Spatiotemporal Characteristics of Dynamic Liver Cancer Microenvironment to Characterize the Clinical Application of Immune Mechanisms in Liver Cancer
Study to Refine the Effectiveness of New Generation Therapies for Suicide
Serial PSMA PET for Therapy Monitoring in Clinically Significant Prostate Cancer
Cognitive Flexibility in Depression and TMS Response
Evaluation of Response by FLT PET in Mesothelioma
Use of Multiparametric MRI in the Management of Head and Neck Cancer: a Prospective Analysis
Feasibility Study of Interval Compressed Regimen Using Four-drugs for Osteosarcoma
Photodynamic Therapy in Locally Advanced Hilar Cholangiocarcinoma